Results 131 to 140 of about 13,462 (146)

Characterizing Post-treatment Lyme Disease Syndrome: A Mixed Methods Study of Patients at a Lyme Disease Clinic in Rhode Island.

Rhode Island medical journal (2013), 2021
Mixed quantitative and qualitative research methods may be useful for characterizing the experiences of patients with post-treatment Lyme disease syndrome.15 participants completed demographic and screening questions, surveys assessing quality of life, fatigue, pain, cognitive functioning, and other patient- reported outcomes, a semi-structured in ...
Sara E, Vargas, Melissa, Guillen, Claire D, Stout, Meghan, McCarthy, Dylan, Canfield, Eric, Tolliver, Sabrina, Cunnane, Timothy, Flanigan   +7 more
openaire   +2 more sources

FLAIR and magnetization transfer imaging of patients with post-treatment Lyme disease syndrome

Neurology, 2001
To determine patterns of abnormalities on cerebral MRI that may characterize subgroups of patients with post-treatment Lyme disease syndrome (PTLDS) and to help identify pathomechanisms of disease.The authors analyzed the distribution of cerebral lesions in a cohort of 27 patients with PTLDS.
K, Morgen, R, Martin, R D, Stone, J, Grafman, N, Kadom, H F, McFarland, A, Marques   +6 more
openaire   +2 more sources

The Use of Dapsone as a Novel “Persister” Drug in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome

Journal of Clinical and Experimental Dermatology Research, 2016
Dapsone (diaminodiphenyl sulfone, i.e., DDS) is commonly used to treat dermatological conditions including acne, dermatitis herpetiformis, and leprosy. Mycobacterium leprae, a known "persister" bacteria, requires long-term treatment with intracellular medications including rifampin and Dapsone.
openaire   +1 more source

A distinct autoimmune signature in Post-treatment Lyme Disease Syndrome (PTLD)

The Journal of Immunology
Abstract Post-Treatment Lyme Disease (PTLD) is characterized as a persistent inflammatory condition in a large fraction of patients following antibiotic treatment for Borreliella infection, but what leads to PTLD is not known. Here, we analyzed 56 peripheral blood mononuclear cell (PBMC) samples from 23 individuals at risk for PTLD in a ...
Xin Chen, Xin Zhou, Haozhen Wang, Xuhuai Ji, Alison Rebman, Mark Soloski, Christine Wagner, Michael Snyder, William Robinson, John Aucott, Mark Davis   +10 more
openaire   +1 more source

Aktuelle integrative und supportive Therapieoptionen bei Post-Treatment Lyme Disease Syndrome (PTLDS) und Chronischer Lyme-Disease (CLD)

Zeitschrift für Orthomolekulare Medizin
ZusammenfassungBei der Lyme-Borreliose übertragen Zecken die Krankheitserreger von infizierten Tieren auf den Menschen. Von der Spätmanifestation der Infektion, auch als „Chronische Lyme-Borreliose“ (CLD) bezeichnet, ist das „Posttherapeutische Lyme-Borreliose-Syndrom“ (PTLDS ...
Uwe Gröber, Michael Kramer, Burkhard Schütz, Thomas Welt   +3 more
openaire   +2 more sources

Inflammation, biofilms and dietary measures in post treatment Lyme disease syndrome

Fatigue: Biomedicine, Health & Behavior, 2022
openaire   +1 more source

Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndrome

Clinical Immunology, 2011
Abhishek Chandra, Norman Latov, Gary P Wormser   +2 more
exaly  

A Small Cohort of Patients with Post Treatment Lyme Disease Syndrome Treated with HIFEM

SSRN Electronic Journal, 2022
openaire   +1 more source

The fibromyalgia impact questionnaire: A useful tool in evaluating patients with post-Lyme disease syndrome

Arthritis and Rheumatism, 1999
Arthur Weinstein
exaly  

Post-Treatment Lyme Disease Syndrome nur ein Phantom?

MMW - Fortschritte der Medizin, 2013
openaire   +1 more source